Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
246.58%Interest Expense Margin
VS
Market
Sector
Industry
History
$ 2.29Close
$ 1.11 - $ 4.65 52-Week Range
Ticker Information
Ticker
SABSCompany Name
SAB BIOTHERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQSAB BIOTHERAPEUTICS INC - Interest Expense Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
SABS - Int. Exp. % Historical data
| Date | Interest Expense | Interest Expense Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 282.82K | 246.58% | $ 114.7K |
| 3/31/2025 | $ 311.6K | 82.47% | $ 377.83K |
| 12/31/2024 | $ 318.4K | 24.08% | $ 1.32M |
| 9/30/2024 | $ 325.4K | 21.51% | $ 1.51M |
| 6/30/2024 | $ 317.07K | 11.41% | $ 2.78M |
| 3/31/2024 | $ 299.27K | 11.5% | $ 2.6M |
| 12/31/2023 | $ 315.28K | 14.08% | $ 2.24M |
| 9/30/2023 | $ 325.1K | 7.94% | $ 4.09M |
| 6/30/2023 | $ 326.03K | 5.08% | $ 6.42M |
| 3/31/2023 | $ 321.95K | 2.54% | $ 12.68M |
Key Performance Insights, Last 5 Years
- SAB BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) Int. Exp. % stands at 0.48%.
- Over the past 5 years, SAB BIOTHERAPEUTICS INC's average Int. Exp. % has been 30.75%.
- The median Int. Exp. % for SAB BIOTHERAPEUTICS INC during this period was 9.67%
- SAB BIOTHERAPEUTICS INC reached its highest Int. Exp. % over the past 5 years at 246.58%.
- The lowest Int. Exp. % recorded by SAB BIOTHERAPEUTICS INC in the same timeframe 0.48%
SAB BIOTHERAPEUTICS INC's Int. Exp. % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Int. Exp. % Benchmarks
Similar metrics to Revenues:
- Interest Expense - [Income Statement] Interest expense is the cost incurred by a business for borrowing funds.
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
Definition of Interest Expense Margin
[Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].Int. Exp. / Revenues
(=) Int. Exp. % Int. Exp. % for SAB BIOTHERAPEUTICS INC is calculated as follows: Int. Exp. [ $ 294.46K ] / Revenues [ $ 60.88M ]
(=) Int. Exp. % [ 0.48% ] SABS - Interest Expense Margin, Last 5 years
0.48%
Minimum
Dec 31, 2021
246.58%
Maximum
Jun 30, 2025
30.75%
Average
9.67%
Median
Int. Exp. % Benchmark AnalysisMarket
The chart above depicts the distribution of Int. Exp. % for companies in the Total Stock Market. The average Int. Exp. % of the companies is 1.62% with a standard deviation of 2.19%.
The following table provides additional summary stats:
Int. Exp. % in the Market:
| filtered constituents | 3.15K |
|---|---|
| min | -4.94% |
| max | 8.48% |
| average | 1.62% |
| median | 0.79% |
| std | 2.19% |